You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Global Briefing

Corporate Strategies in Consumer Health

Feb 2012

Price: US$2,000

About this Report

About this Report

Euromonitor International examines the companies, brands and strategies that shaped the consumer health industry in 2011. This corporate strategies briefing will also highlight the issues facing the industry in the near future, examine the industry's reactions and preparedness, and highlight examples of successful and unsuccessful tactics for dealing with an evolving marketplace.


What this report includes

  • Up-to-the minute analysis of the latest trends in the industry
  • New product development, forecasts and other themes
  • Unique graphics and illustrated case studies
  • Most recent brand and company news
  • New insight into the size and shape of the market

Why buy this report

  • Clear, concise powerpoint format makes it easy to digest
  • Leading industry opinion keeps you abreast of latest news and trends
  • Forward-looking outlook on a category, market or issue affecting the industry
  • Latest five year forecasts assess how the market is predicted to develop
  • Understand the competitive environment, the leading players and brands

Delivery format

PDF/PPT
Downloadable from MyPages

Table of Contents

Table of Contents

Introduction

Scope

Key findings

Consumer Health: An Important Revenue Source

Macroeconomic factors pressure prescription sales

Regulatory hurdles on the horizon for world’s largest market

Consumer health: A stable source of revenue in uncertain times

Growth set to continue in consumer health

Company Performance Summary

Globally, consumer health remains a fragmented market

Winners and losers in 2011

2011: A banner year for Herbalife Ltd

Johnson & Johnson Inc : A cautionary tale

Johnson & Johnson Inc: The gold medal as a silver lining

Brand Performance Summary

Global brand breakdown

Tops and flops in 2011

Brands continue to cross borders for growth opportunities

5-Hour Energy: The US’s home-grown billion dollar brand

Umbrella brands: An opportunity under threat?

Regulatory concerns regarding umbrella branding

The Global Hunt for Growth

Emerging market economies offer attractive fundamentals

Rising per capita consumption and brand equity are key to growth

BRIC: Not the only foundation for international sales growth

Uneven emerging market penetration among global players

Case Study: Bayer AG in emerging markets

Bayer AG’s growth in emerging markets

Acquisitions complement organic growth strategies

The development of a new emerging market focus

Enviable, if uneven, performance across many emerging markets

Key takeaways from a successful emerging market strategy

OTC Switches and Reverse Switches

The Rx-to-OTC switch: New life for old drugs

Major switches in 2011

What ails you? Treatment areas with strong switch potential

Pfizer’s intent to switch Lipitor: A blockbuster in the making?

Reverse switches

Case study: Boehringer Ingelheim’s dedicated switch team

The development of a dedicated Rx-to-OTC switch team

Building on a history of success

Setting an example for the industry

Social Media: An Industry Minefield?

Unparalleled opportunities for consumer engagement

Social media... Now what?

No guidance, but plenty of letters

A case for self-governance?

Pages people “like”: Gold star examples of Big Pharma in Web 2.0

Targeting the wallet through the phone: The rise of mobile apps

New media, new threats

Conclusion

Key Takeaways (1)

Key Takeaways (2)

Definitions of Report

Definitions

Data parameters and report definitions

Report Appendix

Appendix

Samples

Corporate-Strategies-in-Consumer-Health.jpg

my pages

Want to find out more about this report?